Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5876
NanoViricides
NNVC
$33.4M
| $30K | ﹤0.01% |
862
+100
| +13% | +$3.81K |
2013 Q4
6 quarters
|
|
5877
DELISTED
Old Point Financial
OPOF
| $30K | ﹤0.01% |
1,935
-263
| -12% | -$3.99K |
2013 Q4
6 quarters
|
|
|
RLH
5878
DELISTED
Red Lions Hotel Corporation
RLH
| $30K | ﹤0.01% |
3,913
-107,902
| -97% | -$769K |
2013 Q2
8 quarters
|
|
|
CBMG
5879
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $30K | ﹤0.01% |
790
-5,539
| -88% | -$179K |
2014 Q3
3 quarters
|
|
|
GULF
5880
DELISTED
WisdomTree Middle East Dividend Fund
GULF
| $30K | ﹤0.01% |
1,511
+108
| +8% | +$2.21K |
2013 Q3
7 quarters
|
|
|
PLND
5881
DELISTED
VanEck Vectors Poland ETF
PLND
| $30K | ﹤0.01% |
1,724
-5,377
| -76% | -$101K |
2013 Q2
8 quarters
|
|
|
RIC
5882
DELISTED
Richmont Mines Inc.
RIC
| $30K | ﹤0.01% |
9,400
-114,916
| -92% | -$366K |
2014 Q3
3 quarters
|
|
|
ARCW
5883
DELISTED
ARC Group Worldwide, Inc
ARCW
| $30K | ﹤0.01% |
5,586
+7
| +0.1% | +$43 |
2013 Q4
6 quarters
|
|
|
NAME
5884
DELISTED
Rightside Group, Ltd.
NAME
| $30K | ﹤0.01% |
4,456
-280
| -6% | -$2.35K |
2014 Q3
3 quarters
|
|
|
RNWK
5885
DELISTED
RealNetworks Inc
RNWK
| $30K | ﹤0.01% |
5,494
-18,300
| -77% | -$115K |
2013 Q2
8 quarters
|
|
5886
Ascendis Pharma A/S
ASND
$14.9B
| $29K | ﹤0.01% |
1,660
-3,590
| -68% | -$62.8K |
2015 Q1
1 quarter
|
|
5887
CB Financial Services
CBFV
$192M
| $29K | ﹤0.01% |
1,471
-25,988
| -95% | -$517K |
2014 Q4
2 quarters
|
|
5888
Eagle Bancorp Montana
EBMT
$166M
| $29K | ﹤0.01% |
2,708
-999
| -27% | -$10.8K |
2013 Q4
6 quarters
|
|
|
BFYT
5889
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $29K | ﹤0.01% |
5,746
+5,000
| +670% | +$31.5K |
2013 Q4
6 quarters
|
|
|
WCST
5890
DELISTED
Wecast Network, Inc. Common Stock
WCST
| $29K | ﹤0.01% |
13,841
+1
| +0% | +$2 |
2013 Q4
6 quarters
|
|
|
HTCH
5891
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
| $29K | ﹤0.01% |
16,938
-1,972
| -10% | -$4.41K |
2013 Q2
8 quarters
|
|
5892
Alterity Therapeutics
ATHE
$51.2M
| $28K | ﹤0.01% |
400
-11
| -3% | -$826 |
2013 Q3
7 quarters
|
|
5893
Live Ventures
LIVE
$23.5M
| $28K | ﹤0.01% |
1,823
-850
| -32% | -$15.3K |
2013 Q4
6 quarters
|
|
5894
Primoris Services
PRIM
$4.2B
| $28K | ﹤0.01% |
1,430
-6,133
| -81% | -$117K |
2013 Q2
8 quarters
|
|
|
NEPT
5895
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $28K | ﹤0.01% |
15
+1
| +7% | +$2.09K |
2013 Q2
8 quarters
|
|
|
CRCM
5896
DELISTED
CARE.COM, INC.
CRCM
| $28K | ﹤0.01% |
4,747
-2,311
| -33% | -$14.9K |
2014 Q1
5 quarters
|
|
|
SKIS
5897
DELISTED
Peak Resorts, Inc.
SKIS
| $28K | ﹤0.01% |
3,970
+1,395
| +54% | +$9.41K |
2014 Q4
2 quarters
|
|
|
DDE
5898
DELISTED
Dover Downs Gaming & Entertain
DDE
| $28K | ﹤0.01% |
30,298
-9,602
| -24% | -$10.8K |
2015 Q1
1 quarter
|
|
5899
Bel Fuse Inc Class A
BELFA
$2.6B
| $27K | ﹤0.01% |
1,432
-259
| -15% | -$5.21K |
2013 Q4
6 quarters
|
|
5900
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$5.64M
| $27K | ﹤0.01% |
+109
| New | +$24.2K |
2015 Q2
0 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.